This advert is not available!
The “Cancer Therapy” group at the Karolinska Institutet – SciLifeLab, led by Prof. Oscar Fernandez-Capetillo is looking for postdoc candidates, with proven experience in cell and molecular biology and that want to expand their training towards phenotypic chemical and genetic screens related to cancer and other age-related diseases. Our research group is an international team surrounded by strong national facilities and actively collaborates with other competitive national and international research groups.
For further information visit: http://ki.se/en/mbb/oscar-fernandez-capetillo-group
The aim of our group is to capitalize on our expertise in High-Content Imaging to conduct genetic and chemical screens that can help us discover new strategies to combat human disease. Our group is integrated in the "Genome Biology" Division at Karolinska Institutet, together with other competitive groups that work in areas such as DNA repair, epigenetics, advanced imaging or genomics (https://ki.se/en/mbb/research-division-of-genome-biology). We are located at SciLifeLab, where our team is surrounded by other world leaders in various biomedical research areas, and has access to national facilities for proteomics, advanced microscopy, next generation sequencing etc.
We are looking for a postdoctoral scientist to join our team with a recent Ph.D. in Cell Biology, Molecular Biology, Biochemistry or any other relevant field. A background in senescence, cell cycle, DNA damage signaling or neurodegeneration would be a merit. We are specifically looking for a highly motivated scientist, who aims to complement his/her skills with experience in large chemical and genetic screens and has the capacity to independently drive a scientific research project that relies mostly on cell and molecular biology technologies. In addition, it is expected that the candidate will help in the training of junior group members. Other valuable skills such as writing or presenting capacities or social skills will also be appreciated.
Bases of assessment
Scientific merit is the essential basis of our assessment. All applications will be internally reviewed, and the assessment done according to the applicant’s competence (publications, experience, distinctions, and other relevant research merits). The applicant must have a strong background in cell and molecular biology. Experience in cancer or neurodegeneration research and/or high-throughput imaging and screenings is considered as a merit. Selected applicants will be interviewed at a second stage before making the final decision.
Scholarships for postdoctoral qualification can be established for foreign researchers who place their qualifications in Sweden. The purpose of scholarships for postdoctoral qualification is to promote internationalization and contribute to research qualification after a doctorate or equivalent.
A scholarship for carrying out postdoctoral research can be granted for a maximum of two years within a four year period following the receipt of a doctoral degree or equivalent.
To be eligible for a postdoctoral scholarship, the person must have obtained a doctorate or a foreign degree deemed to be equivalent to a doctorate. Applicants who have not completed a doctorate at the end of the application period may also apply, provided that all requirements for a completed degree are met before the (intended) start date of the post doctoral education.
The head of the department determines whether their previous training and scholarly qualifications correspond to a Swedish doctorate or higher.
Location: Solna, SciLifeLab
The amount is tax free and it is set for twelve months at a time, paid out on a six months basis. In exceptional cases, shorter periods may be acceptable.
An application must contain the following documents in English or Swedish:
The application is to be submitted on the Varbi recruitment system.
First day of employment | Upon agreement |
---|---|
Salary | Scholarship |
Reference number | STÖD 2-1422/2023 |
Contact |
|
Published | 03.Apr.2023 |
Last application date | 10.May.2023 11:59 PM CEST |